During a call this week to discuss its second-quarter finances, Myriad Genetics acknowledged that its flagship BRACAnalysis product will likely begin to face competition in the market by 2018, when its core BRCA patents expire.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Science this week: CRISPR-based barcodes to trace cell lineages, and more.
The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.
French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.
Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.